By targeting miR-200a-3p, tumorous exosome-mediated transfer of circ_UBE2D2 could enhance tamoxifen resistance of BC cells by regulating cell viability, metastasis, and the level of ERa in vivo and in vitro. Here, UBE2D2 is linked to breast cancer.